RL
56
3
TXN
35
6
ORLY
52
3
MOS
36
7
WY
33
2
ADI
41
3
PRGO
31
4
QCOM
46
6
WU
38
8
FTI
40
-5
STX
35
4
GOOG
57
13
FSLR
46
14
SLG
41
3
CMI
45
2
TAP
60
2
R
63
2
SE
61
4
COP
30
5
ROK
26
2
RL
56
3
TXN
35
6
ORLY
52
3
MOS
36
7
WY
33
2
ADI
41
3
PRGO
31
4
QCOM
46
6
WU
38
8
FTI
40
-5
STX
35
4
GOOG
57
13
FSLR
46
14
SLG
41
3
CMI
45
2
TAP
60
2
R
63
2
SE
61
4
COP
30
5
ROK
26
2
Financhill
Back

Sage Therapeutics Stock Price Chart

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
38

SAGE
Sage Therapeutics

Last Price:
$7.39
Seasonality Move:
7.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Mode Mobile Could be Next in Line

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • The current trend is relatively stagnant and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Sage Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 7.01 Buy
20-day SMA: 7.71 Sell
50-day SMA: 7.48 Sell
200-day SMA: 7.62 Sell
8-day EMA: 7.11 Buy
20-day EMA: 7.41 Sell
50-day EMA: 7.36 Sell
200-day EMA: 9 Sell

Sage Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 44.75 Sell
Chaikin Money Flow: 927800 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.09 - 8.29) Sell
Bollinger Bands (100): (5.64 - 7.7) Buy

Sage Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Sage Therapeutics Stock

Is Sage Therapeutics Stock a Buy?

  • Sage Therapeutics share price is 7.16 while SAGE 8-day simple moving average is 7.01, which is a Buy signal.
  • The stock price of SAGE is 7.16 while Sage Therapeutics 20-day SMA is 7.71, which makes it a Sell.
  • Sage Therapeutics 50-day simple moving average is 7.48 while SAGE share price is 7.16, making it a Sell technically.
  • SAGE stock price is 7.16 and Sage Therapeutics 200-day simple moving average is 7.62, creating a Sell signal.

SAGE Technical Analysis vs Fundamental Analysis

Sell
38
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics a Buy or a Sell?

  • Sage Therapeutics stock is rated a Sell
    The current Sage Therapeutics [SAGE] share price is $7.16. The Score for SAGE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.

Sage Therapeutics Stock Info

Market Cap:
440.2M
Price in USD:
7.16
Share Volume:
1.1M

Sage Therapeutics 52-Week Range

52-Week High:
16.37
52-Week Low:
4.62
Sell
38
Sage Therapeutics (SAGE) is a Sell

Sage Therapeutics Share Price Forecast

Is Sage Therapeutics Stock a Buy?

  • Sage Therapeutics share price is 7.16 while SAGE 8-day exponential moving average is 7.11, which is a Buy signal.
  • The stock price of SAGE is 7.16 while Sage Therapeutics 20-day EMA is 7.41, which makes it a Sell.
  • Sage Therapeutics 50-day exponential moving average is 7.36 while SAGE share price is 7.16, making it a Sell technically.
  • SAGE stock price is 7.16 and Sage Therapeutics 200-day simple moving average is 9.00, creating a Sell signal.

Fundamental Analysis of Sage Therapeutics

Is Sage Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.41 per share, an increase this year of $2.68 per share, and an increase next year of $1.19 per share.

Technical Analysis of Sage Therapeutics

Should I short Sage Therapeutics stock?

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.